White label – Pompe disease - ClinicalTrials.eu

A study testing etentamig alone or with drug combinations in adult patients with multiple myeloma to assess safety and changes in disease activity

Recruiting

1 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

Recruiting

2 1
Investigated Diseases:
- Alport’s syndrome
- Chronic kidney disease
+1
Study of ECI830, ribociclib, and fulvestrant in patients with advanced hormone receptor positive, HER2-negative breast cancer and advanced solid tumors

Recruiting

2 1 1 1
Investigated Diseases:
- Hormone receptor positive HER2 negative breast cancer
- Neoplasm malignant
Investigated Drugs:
A study comparing furazidin and clindamycin for women with bacterial vaginosis

Recruiting

3 1 1 1
Investigated Diseases:
- Bacterial vaginosis
Investigated Drugs:
- Clindamycin Phosphate
Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

Recruiting

3 1
Investigated Diseases:
- Short-bowel syndrome
Investigated Drugs:
- Glepaglutide
+9
A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

Recruiting

4 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
+5
A study testing GSK3862995B compared to placebo for safety and effectiveness in adults aged 18 to 85 years with bronchiectasis

Recruiting

2 1
Investigated Drugs:
- GSK3862995B
A study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans

Recruiting

2 1
Investigated Diseases:
- Progressive multiple sclerosis
Investigated Drugs:
- ACT-1004-1239
A study comparing under-the-skin and into-the-vein alpha1-proteinase inhibitor treatment in patients with alpha1-antitrypsin deficiency

Recruiting

3 1 1
Investigated Drugs:
- Human Alpha1-Proteinase Inhibitor
+3
A Study of Sodium Selenite Followed by Chemotherapy in Patients with Advanced Cancer

Recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- SODIUM SELENITE PENTAHYDRATE

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies